[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Avalo Therapeutics Inc (AVTX)

Avalo Therapeutics Inc (AVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Avalo Therapeutics Inc 1500 Liberty Ridge Drive Suite 321 Wayne PA 19087 USA

www.avalotx.com Employees: 33 P: 410-522-8707

Sector:

Medical

Description:

Avalo Therapeutics Inc. is a clinical-stage precision medicine company which discovers, develops and commercializes targeted therapeutics for patients with significant unmet clinical need in immunology, immuno-oncology and rare genetic diseases. Avalo Therapeutics Inc., formerly known as Cerecor, is based in WAYNE, Pa.

Key Statistics

Overview:

Market Capitalization, $K 1,069,919
Enterprise Value, $K 1,054,019
Shares Outstanding, K 53,630
Float, K 51,238
% Float 95.54%
Short Interest, K 12,950
Short Float 24.15%
Days to Cover 14.38
Short Volume Ratio 0.62
% of Insider Shareholders 4.46%
% of Institutional Shareholders 87.06%

Financials:

Annual Sales, $ 60 K
Annual Net Income, $ -78,260 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -19,630 K
EBIT, $ -79,220 K
EBITDA, $ -78,880 K

Growth:

1-Year Return 121.30%
3-Year Return -18.74%
5-Year Return -99.77%
5-Year Revenue Growth -99.10%
5-Year Earnings Growth 99.64%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.83 on 08/06/26
Next Earnings Date 11/05/26
Earnings Per Share ttm -5.46
EPS Growth vs. Prev Qtr 15.31%
EPS Growth vs. Prev Year 56.77%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-240 on 12/29/23

AVTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -58.03%
Return-on-Assets % -48.22%
Profit Margin % -130,433.34%
Debt/Equity 0.00
Price/Sales 17,806.98
Price/Cash Flow N/A
Price/Book 2.29
Book Value/Share 2.56
Interest Coverage -2.41
60-Month Beta 0.80
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.